US Stock MarketDetailed Quotes

TARA Protara Therapeutics

Watchlist
  • 3.370
  • -0.020-0.59%
Close May 6 16:00 ET
  • 3.371
  • +0.001+0.04%
Pre 08:00 ET
130.01MMarket Cap-1.55P/E (TTM)

Protara Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
12.70%49.15M
29.63%14.31M
15.23%12.33M
-12.18%10.66M
21.77%11.85M
16.16%43.61M
10.50%11.04M
34.19%10.7M
39.46%12.14M
-10.50%9.73M
Selling and administrative expenses
-6.30%17.45M
3.28%4.81M
-4.95%4.26M
-12.65%4.27M
-10.59%4.1M
-10.19%18.62M
-6.86%4.66M
-0.58%4.48M
-12.95%4.89M
-18.13%4.59M
-General and administrative expense
-6.30%17.45M
3.28%4.81M
-4.95%4.26M
-12.65%4.27M
-10.59%4.1M
-10.19%18.62M
-6.86%4.66M
-0.58%4.48M
-12.95%4.89M
-18.13%4.59M
Research and development costs
26.87%31.7M
48.86%9.5M
29.78%8.07M
-11.87%6.39M
50.65%7.75M
48.67%24.99M
27.90%6.38M
79.40%6.22M
134.99%7.25M
-2.39%5.14M
Operating profit
-12.70%-49.15M
-29.63%-14.31M
-15.23%-12.33M
12.18%-10.66M
-21.77%-11.85M
-16.16%-43.61M
-10.50%-11.04M
-34.19%-10.7M
-39.46%-12.14M
10.50%-9.73M
Net non-operating interest income expense
29.99%4.14M
41.03%1.15M
31.62%1.1M
35.04%1.14M
8.73%747K
191.03%3.18M
55.05%814K
196.11%838K
407.23%842K
477.31%687K
Non-operating interest income
29.99%4.14M
41.03%1.15M
31.62%1.1M
35.04%1.14M
8.73%747K
42.65%3.18M
28.80%814K
50.45%838K
64.45%842K
29.87%687K
Other net income (expense)
3,425.00%423K
6,483.33%395K
300.00%8K
175.00%11K
9K
100.04%12K
6K
2K
4K
Gain on sale of security
200.00%36K
33.33%8K
300.00%8K
175.00%11K
--9K
-29.41%12K
--6K
--2K
--4K
----
Other non- operating income (expenses)
--387K
----
----
----
----
----
----
----
----
----
Income before tax
-10.33%-44.6M
-24.93%-12.77M
-13.78%-11.22M
15.77%-9.51M
-22.66%-11.1M
38.71%-40.42M
73.77%-10.22M
-28.20%-9.86M
-32.26%-11.29M
15.90%-9.05M
Income tax
Net income
-10.33%-44.6M
-24.93%-12.77M
-13.78%-11.22M
15.77%-9.51M
-22.66%-11.1M
38.71%-40.42M
73.77%-10.22M
-28.20%-9.86M
-32.26%-11.29M
15.90%-9.05M
Net income continuous Operations
-10.33%-44.6M
-24.93%-12.77M
-13.78%-11.22M
15.77%-9.51M
-22.66%-11.1M
38.71%-40.42M
73.77%-10.22M
-28.20%-9.86M
-32.26%-11.29M
15.90%-9.05M
Minority interest income
Net income attributable to the parent company
-10.33%-44.6M
-24.93%-12.77M
-13.78%-11.22M
15.77%-9.51M
-22.66%-11.1M
38.71%-40.42M
73.77%-10.22M
-28.20%-9.86M
-32.26%-11.29M
15.90%-9.05M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-10.33%-44.6M
-24.93%-12.77M
-13.78%-11.22M
15.77%-9.51M
-22.66%-11.1M
38.71%-40.42M
73.77%-10.22M
-28.20%-9.86M
-32.26%-11.29M
15.90%-9.05M
Basic earnings per share
39.22%-2.17
46.67%-0.48
42.53%-0.5
55.00%-0.45
-21.25%-0.97
39.08%-3.57
73.99%-0.9
-27.94%-0.87
-31.58%-1
16.67%-0.8
Diluted earnings per share
39.22%-2.17
46.67%-0.48
42.53%-0.5
55.00%-0.45
-21.25%-0.97
39.08%-3.57
73.99%-0.9
-27.94%-0.87
-31.58%-1
16.67%-0.8
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 12.70%49.15M29.63%14.31M15.23%12.33M-12.18%10.66M21.77%11.85M16.16%43.61M10.50%11.04M34.19%10.7M39.46%12.14M-10.50%9.73M
Selling and administrative expenses -6.30%17.45M3.28%4.81M-4.95%4.26M-12.65%4.27M-10.59%4.1M-10.19%18.62M-6.86%4.66M-0.58%4.48M-12.95%4.89M-18.13%4.59M
-General and administrative expense -6.30%17.45M3.28%4.81M-4.95%4.26M-12.65%4.27M-10.59%4.1M-10.19%18.62M-6.86%4.66M-0.58%4.48M-12.95%4.89M-18.13%4.59M
Research and development costs 26.87%31.7M48.86%9.5M29.78%8.07M-11.87%6.39M50.65%7.75M48.67%24.99M27.90%6.38M79.40%6.22M134.99%7.25M-2.39%5.14M
Operating profit -12.70%-49.15M-29.63%-14.31M-15.23%-12.33M12.18%-10.66M-21.77%-11.85M-16.16%-43.61M-10.50%-11.04M-34.19%-10.7M-39.46%-12.14M10.50%-9.73M
Net non-operating interest income expense 29.99%4.14M41.03%1.15M31.62%1.1M35.04%1.14M8.73%747K191.03%3.18M55.05%814K196.11%838K407.23%842K477.31%687K
Non-operating interest income 29.99%4.14M41.03%1.15M31.62%1.1M35.04%1.14M8.73%747K42.65%3.18M28.80%814K50.45%838K64.45%842K29.87%687K
Other net income (expense) 3,425.00%423K6,483.33%395K300.00%8K175.00%11K9K100.04%12K6K2K4K
Gain on sale of security 200.00%36K33.33%8K300.00%8K175.00%11K--9K-29.41%12K--6K--2K--4K----
Other non- operating income (expenses) --387K------------------------------------
Income before tax -10.33%-44.6M-24.93%-12.77M-13.78%-11.22M15.77%-9.51M-22.66%-11.1M38.71%-40.42M73.77%-10.22M-28.20%-9.86M-32.26%-11.29M15.90%-9.05M
Income tax
Net income -10.33%-44.6M-24.93%-12.77M-13.78%-11.22M15.77%-9.51M-22.66%-11.1M38.71%-40.42M73.77%-10.22M-28.20%-9.86M-32.26%-11.29M15.90%-9.05M
Net income continuous Operations -10.33%-44.6M-24.93%-12.77M-13.78%-11.22M15.77%-9.51M-22.66%-11.1M38.71%-40.42M73.77%-10.22M-28.20%-9.86M-32.26%-11.29M15.90%-9.05M
Minority interest income
Net income attributable to the parent company -10.33%-44.6M-24.93%-12.77M-13.78%-11.22M15.77%-9.51M-22.66%-11.1M38.71%-40.42M73.77%-10.22M-28.20%-9.86M-32.26%-11.29M15.90%-9.05M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -10.33%-44.6M-24.93%-12.77M-13.78%-11.22M15.77%-9.51M-22.66%-11.1M38.71%-40.42M73.77%-10.22M-28.20%-9.86M-32.26%-11.29M15.90%-9.05M
Basic earnings per share 39.22%-2.1746.67%-0.4842.53%-0.555.00%-0.45-21.25%-0.9739.08%-3.5773.99%-0.9-27.94%-0.87-31.58%-116.67%-0.8
Diluted earnings per share 39.22%-2.1746.67%-0.4842.53%-0.555.00%-0.45-21.25%-0.9739.08%-3.5773.99%-0.9-27.94%-0.87-31.58%-116.67%-0.8
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Market Insights

U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

Unlock Now

Discussing

Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More